Related Articles
Targeted disruption of S100P suppresses tumor cell growth by down-regulation of cyclin D1 and CDK2 in human hepatocellular carcinoma
Down-regulation of transforming growth factor β receptor type III in hepatocellular carcinoma is not directly associated with genetic alterations or loss of heterozygosity
Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags
Hs.137007 is a novel epigenetic marker hypermethylated and up-regulated in breast cancer
Cell-cycle regulators, bcl-2 and NF-κB in Epstein-Barr virus-positive gastric carcinomas